GlassScriptPhysician profile
Sara A Westgate
NPI 1336147941
$2,937.90
in general payments reported to CMS, 2019-2025
36 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,253 · 2020: $477 · 2021: $125 · 2022: $53.21 · 2023: $29.07.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $29.07.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $29.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $351.72 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $214.17 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $213.69 | 2019-2020 | |
| Lilly USA, LLC | $205.33 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $180.61 | 2019 | |
| Supernus Pharmaceuticals, INC. | $175.26 | 2019-2020 | |
| Mdd US Operations, LLC | $169.33 | 2019-2020 | |
| Acorda Therapeutics, INC | $168.64 | 2019 | |
| Amgen INC. | $168.35 | 2020-2022 | |
| Acadia Pharmaceuticals INC | $102.32 | 2019-2020 | |
| Amneal Pharmaceuticals LLC | $95.17 | 2019 | |
| Genentech USA, INC. | $92.98 | 2019 | |
| Emd Serono, INC. | $90.89 | 2019-2023 | |
| Lundbeck LLC | $84.96 | 2019 | |
| Abbott Laboratories | $54.70 | 2019 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch Health US, LLC | $50.43 | 2019 | |
| Biogen, INC. | $44.44 | 2019-2020 | |
| Merz North America, INC. | $42.14 | 2019 | |
| Genzyme Corporation | $39.42 | 2019 | |
| Upsher-Smith Laboratories LLC | $32.60 | 2019 | |
| Ge Healthcare | $32.02 | 2020 | |
| Zyla Life Sciences, INC. | $31.94 | 2019-2020 | |
| Adamas Pharmaceuticals, INC. | $31.35 | 2019 | |
| Abbvie INC. | $29.80 | 2019-2022 | |
| Ucb, INC. | $27.13 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $26.87 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $25.65 | 2019 | |
| Pfizer INC. | $22.35 | 2019 | |
| Avanir Pharmaceuticals, INC. | $22.02 | 2019 | |
| Grifols USA, LLC | $20.29 | 2019 | |
| Assertio Therapeutics, INC. | $18.38 | 2020 | |
| Currax Pharmaceuticals LLC | $17.64 | 2020 | |
| Vertical Pharmaceuticals, LLC | $15.81 | 2019 | |
| Arbor Pharmaceuticals, INC. | $13.92 | 2019 | |
| Csl Behring | $13.61 | 2019 | |
| Livanova USA, INC. | $11.97 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Westgate listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.